Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production

Highlights • Riluzole leads to a suppression of cell proliferation in liver cancer cells. • Riluzole induced caspase-dependent apoptosis and G2/M cell cycle arrest. • Riluzole-treated cells have increased level of inner cellular glutamate • Riluzole-treated cells have decrease the glutathione (GSH)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2016-11, Vol.382 (2), p.157-165
Hauptverfasser: Seol, Hyang Sook, Lee, Sang Eun, Song, Joon Seon, Lee, Hye Yong, Park, Sojung, Kim, Inki, Singh, Shree Ram, Chang, Suhwan, Jang, Se Jin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Riluzole leads to a suppression of cell proliferation in liver cancer cells. • Riluzole induced caspase-dependent apoptosis and G2/M cell cycle arrest. • Riluzole-treated cells have increased level of inner cellular glutamate • Riluzole-treated cells have decrease the glutathione (GSH) level and increase reactive oxygen species (ROS) production. • Riluzole-induced GSH and ROS changes in a Huh7 xenograft cancer model.
ISSN:0304-3835
1872-7980
DOI:10.1016/j.canlet.2016.08.028